The medication semaglutide (Wegovy) received FDA approval for treatment of obesity in 2021. More common prescription weight loss drugs which have been in use longer include: Liraglutide, bupropion/naltrexone (contrave) , phentermine- multiple doses , Phentermine-Topiramate combination (Qysmia), and other GLP-1 agonist or GIP/GLP-1 agonists. Newer drugs will be revealed in 2023.
We will customize a medication program that suits your needs. Every medication has a mechanism for its help with weight loss. In addition, they all have various side-effect profiles.
GLP-1 Agonists include Liraglutide (Saxenda), Dulaglutide (Trulicity), Semaglutide (Wegovy),Exenatide extended release (Bydureon bcise) (weekly), Exenatide (Byetta) (twice daily). GLP-1RAs work by reducing the appetite and feelings of hunger, slowing the release of food from the stomach, and increasing feelings of fullness after eating
Tirzepatide (Mounjaro) which is approved for use in T2DM can also help you lose weight with dual actions similar to GLP1 Agonists.
WHAT ARE COMPOUNDED GLP-1 MEDICATIONS?
Because of the shortage in semaglutide and other GLP-1s we have sourced specialty pharmacies that can make those medications for off-label weight loss use.